These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1311 related articles for article (PubMed ID: 28075466)
21. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy. Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794 [TBL] [Abstract][Full Text] [Related]
22. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles. Wang J; Ma W; Tu P Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672 [TBL] [Abstract][Full Text] [Related]
23. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
24. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation. Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776 [TBL] [Abstract][Full Text] [Related]
25. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles. Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221 [TBL] [Abstract][Full Text] [Related]
26. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
27. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
28. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance. Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203 [TBL] [Abstract][Full Text] [Related]
29. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery. Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310 [TBL] [Abstract][Full Text] [Related]
30. Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497 [TBL] [Abstract][Full Text] [Related]
31. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
32. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy. Wu G; Wang Z; Bian X; Du X; Wei C Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652 [TBL] [Abstract][Full Text] [Related]
33. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release. Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273 [TBL] [Abstract][Full Text] [Related]
34. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy. Hu Q; Wang Y; Xu L; Chen D; Cheng L Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053 [TBL] [Abstract][Full Text] [Related]
35. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth. Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606 [TBL] [Abstract][Full Text] [Related]
36. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050 [TBL] [Abstract][Full Text] [Related]
37. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818 [TBL] [Abstract][Full Text] [Related]
38. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923 [TBL] [Abstract][Full Text] [Related]
39. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147 [TBL] [Abstract][Full Text] [Related]
40. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]